文献速递癫痫

立体定向激光杏仁核海马毁损术治疗内侧颞叶癫痫

Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy.
PubMed 文献 · Ann Neurol · 2018-03-03

该研究回顾性评估了58例内侧颞叶癫痫患者接受立体定向激光杏仁核海马毁损术后的疗效,随访至少12个月。术后1年53.4%(95%CI=40.8-65.7%)的患者无致残性发作,有海马硬化者无发作率为60.5%(95%CI=45.6-73.7%),无海马硬化者为33.3%(95%CI=15.0-58.5%)。作者认为该微创手术是切除手术的有效替代方案,但无发作率低于开放手术。

要点

  • 术后1年53.4%(95%CI=40.8-65.7%)的患者无致残性发作(Engel I级)。
  • 有海马硬化者无发作率为60.5%(95%CI=45.6-73.7%),无海马硬化者为33.3%(95%CI=15.0-58.5%)。
  • 9例复发患者中3例再次消融后无发作,且该手术不影响后续开放手术。

核心结论

  • 在未经选择的连续病例中,立体定向激光杏仁核海马毁损术的无发作率低于但堪比开放颞叶手术的典型结果。
  • 与开放手术类似,无海马硬化的患者疗效较差。
  • 该新术式是切除手术的有效微创替代方案。
  • 少数未无发作的患者,激光消融不会阻碍额外的开放手术。

研究设计与样本

  • 回顾性评估连续58例内侧颞叶癫痫患者在本机构接受立体定向激光杏仁核海马毁损术后的手术结局,随访至少12个月。
  • 进行亚组分析,比较有和无内侧颞叶硬化患者。

主要发现

  • 术后1年,全部患者中53.4%(95%CI=40.8-65.7%)无致残性发作(Engel I级)。
  • 9例患者中3例在重复消融后无发作。
  • 有内侧颞叶硬化者60.5%(95%CI=45.6-73.7%)无致残性发作,无内侧颞叶硬化者33.3%(95%CI=15.0-58.5%)无致残性发作。
  • 癫痫生活质量-31评分在组水平显著改善,观察到少数手术相关并发症,言语记忆结局优于历史开放切除数据。

临床怎么用

  • 作者认为该新术式是切除手术的有效微创替代方案。
  • 作者指出少数未无发作的患者,激光消融不会阻碍额外的开放手术。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the outcomes 1 year and longer following stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy in a large series of patients treated over a 5-year period since introduction of this novel technique. METHODS: Surgical outcomes of a consecutive series of 58 patients with mesial temporal lobe epilepsy who underwent the surgery at our institution with at least 12 months of follow-up were retrospectively evaluated. A subgroup analysis was performed comparing patients with and without mesial temporal sclerosis. RESULTS: One year following stereotactic laser amygdalohippocampotomy, 53.4% (95% confidence interval [CI] = 40.8-65.7%) of all patients were free of disabling seizures (Engel I). Three of 9 patients became seizure-free following repeat ablation. Subgroup analysis showed that 60.5% (95% CI = 45.6-73.7%) of patients with mesial temporal sclerosis were free of disabling seizures as compared to 33.3% (95% CI = 15.0-58.5%) of patients without mesial temporal sclerosis. Quality of Life in Epilepsy-31 scores significantly improved at the group level, few procedure-related complications were observed, and verbal memory outcome was better than historical open resection data. INTERPRETATION: In an unselected consecutive series of patients, stereotactic laser amygdalohippocampotomy yielded seizure-free rates for patients with mesial temporal lobe epilepsy lower than, but comparable to, the outcomes typically associated with open temporal lobe surgery. Analogous to results from open surgery, patients without mesial temporal sclerosis fared less well. This novel procedure is an effective minimally invasive alternative to resective surgery. In the minority of patients not free of disabling seizures, laser ablation presents no barrier to additional open surgery. Ann Neurol 2018;83:575-587.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Gross RE, Stern MA, Willie JT, et al. Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Ann Neurol. 2018. PMID: 29420840. doi:10.1002/ana.25180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。